DE60319739D1 - Escitalopramhydrobromid und ein verfahren zu dessen herstellung - Google Patents

Escitalopramhydrobromid und ein verfahren zu dessen herstellung

Info

Publication number
DE60319739D1
DE60319739D1 DE60319739T DE60319739T DE60319739D1 DE 60319739 D1 DE60319739 D1 DE 60319739D1 DE 60319739 T DE60319739 T DE 60319739T DE 60319739 T DE60319739 T DE 60319739T DE 60319739 D1 DE60319739 D1 DE 60319739D1
Authority
DE
Germany
Prior art keywords
escitalopramhydrobromide
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60319739T
Other languages
English (en)
Other versions
DE60319739T2 (de
Inventor
Lawrence Martel
Robert Dancer
Hans Petersen
Peter Ellegaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60319739(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of DE60319739D1 publication Critical patent/DE60319739D1/de
Publication of DE60319739T2 publication Critical patent/DE60319739T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60319739T 2002-12-23 2003-12-18 Escitalopramhydrobromid und ein verfahren zu dessen herstellung Expired - Lifetime DE60319739T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200202005 2002-12-23
DKPA200202005 2002-12-23
PCT/DK2003/000902 WO2004056791A1 (en) 2002-12-23 2003-12-18 Escitalopram hydrobromide and a method for the preparation thereof

Publications (2)

Publication Number Publication Date
DE60319739D1 true DE60319739D1 (de) 2008-04-24
DE60319739T2 DE60319739T2 (de) 2008-07-17

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60319739T Expired - Lifetime DE60319739T2 (de) 2002-12-23 2003-12-18 Escitalopramhydrobromid und ein verfahren zu dessen herstellung

Country Status (33)

Country Link
US (1) US20040167209A1 (de)
EP (1) EP1578738B1 (de)
JP (2) JP4658613B2 (de)
KR (1) KR20050086933A (de)
CN (1) CN100349885C (de)
AR (1) AR042652A1 (de)
AT (1) ATE388947T1 (de)
AU (1) AU2003287919B2 (de)
BR (1) BR0317623A (de)
CA (1) CA2511142A1 (de)
CY (1) CY1107451T1 (de)
DE (1) DE60319739T2 (de)
DK (1) DK1578738T3 (de)
EA (1) EA013116B1 (de)
EG (1) EG24729A (de)
ES (1) ES2298595T3 (de)
HK (1) HK1087708A1 (de)
IL (1) IL169125A0 (de)
IS (1) IS2654B (de)
ME (1) MEP5808A (de)
MX (1) MXPA05005772A (de)
MY (1) MY135468A (de)
NO (1) NO20053595L (de)
NZ (1) NZ540281A (de)
PE (1) PE20040924A1 (de)
PL (1) PL378275A1 (de)
PT (1) PT1578738E (de)
RS (1) RS51092B (de)
TW (1) TW200501943A (de)
UA (1) UA80170C2 (de)
UY (1) UY28148A1 (de)
WO (1) WO2004056791A1 (de)
ZA (1) ZA200504109B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
CA2558198A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CA2625835A1 (en) * 2005-10-14 2007-05-10 Forest Laboratories, Inc. Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
EA200801080A1 (ru) * 2005-10-14 2009-02-27 Х. Лундбекк А/С Стабильные фармацевтические лекарственные формы, содержащие эсциталопрам и бупропион
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
US8030303B2 (en) 2006-07-11 2011-10-04 Mitsubishi Tanabe Pharma Corporation Salt of morpholine compound
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
CN111194312A (zh) * 2017-10-09 2020-05-22 提瓦制药工业公司 依地普仑的新盐和固态形式
US20240100012A1 (en) 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
HUP0200169A3 (en) * 1999-10-25 2002-11-28 Lundbeck & Co As H Method for the preparation of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
EP1339817B1 (de) * 2000-12-04 2007-06-13 Westfalia Separator AG Verfahren zur herstellung von fettsaüreestern
IL158031A0 (en) * 2001-05-01 2004-03-28 Lundbeck & Co As H The use of enantiomeric pure escitalopram
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
BR0317623A (pt) 2005-11-29
MXPA05005772A (es) 2005-08-16
EA013116B1 (ru) 2010-02-26
RS20050487A (en) 2007-06-04
RS51092B (sr) 2010-10-31
AU2003287919A1 (en) 2004-07-14
CY1107451T1 (el) 2012-12-19
JP4658613B2 (ja) 2011-03-23
IS2654B (is) 2010-08-15
NO20053595L (no) 2005-09-05
IS7848A (is) 2005-05-17
MEP5808A (xx) 2010-02-10
AU2003287919B2 (en) 2009-11-12
UY28148A1 (es) 2004-09-30
EA200501046A1 (ru) 2005-12-29
UA80170C2 (en) 2007-08-27
MY135468A (en) 2008-04-30
ATE388947T1 (de) 2008-03-15
JP2011037893A (ja) 2011-02-24
WO2004056791A1 (en) 2004-07-08
EP1578738A1 (de) 2005-09-28
PT1578738E (pt) 2008-04-11
KR20050086933A (ko) 2005-08-30
CN100349885C (zh) 2007-11-21
US20040167209A1 (en) 2004-08-26
ES2298595T3 (es) 2008-05-16
PL378275A1 (pl) 2006-03-20
CN1726202A (zh) 2006-01-25
IL169125A0 (en) 2009-02-11
AR042652A1 (es) 2005-06-29
DK1578738T3 (da) 2008-06-30
CA2511142A1 (en) 2004-07-08
EP1578738B1 (de) 2008-03-12
NZ540281A (en) 2008-07-31
EG24729A (en) 2010-06-21
PE20040924A1 (es) 2004-12-11
HK1087708A1 (en) 2006-10-20
DE60319739T2 (de) 2008-07-17
JP2006514952A (ja) 2006-05-18
TW200501943A (en) 2005-01-16
ZA200504109B (en) 2006-08-30

Similar Documents

Publication Publication Date Title
DE60305105D1 (de) Aluminiumbeschichtetes Bauteil und Verfahren zu dessen Herstellung
DE50302478D1 (de) Elektrode und ein verfahren zu deren herstellung
DE60325672D1 (de) Ein absorbierender Kern und Verfahren zu dessen Herstellung
DE50212077D1 (de) Piezoelektrisches bauelement und verfahren zu dessen herstellung
DE60206141D1 (de) Honigwabenfilter und verfahren zu dessen herstellung
DE60324376D1 (de) Halbleiterbauelement und Verfahren zu dessen Herstellung
DE60332953D1 (de) Gleichmässiges faservlies und verfahren zu dessen herstellung
DE60208867D1 (de) Ventil und ein Verfahren zu dessen Herstellung
DE60202175D1 (de) Formwerkzeug und Verfahren zu dessen Herstellung
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
DE60336185D1 (de) MEMS-Bauelemente und Verfahren zu deren Herstellung
DE602004026985D1 (de) Filter mit Wabenkörperstruktur und Verfahren zu dessen Herstellung
DE60313818D1 (de) Dialysator und Verfahren zu dessen Herstellung
DE50214272D1 (de) Piezoelektrisches bauelement und verfahren zu dessen herstellung
DE60319739D1 (de) Escitalopramhydrobromid und ein verfahren zu dessen herstellung
DE50307832D1 (de) Schichtsystem und verfahren zu dessen herstellung
DE60110216D1 (de) Dichtungsband und Verfahren zu dessen Herstellung
ATE395465T1 (de) Stopfpickel und verfahren zu dessen herstellung
DE60316056D1 (de) Nanoröhrenthermometer und ein Verfahren zu dessen Herstellung
DE50305655D1 (de) Piezoaktor und ein verfahren zu dessen herstellung
DE60238959D1 (de) Piezoelektrischer Oszillator und Verfahren zu dessen Herstellung
DE60308125D1 (de) Verbinder und Verfahren zu dessen Herstellung
DE60229488D1 (de) Piezoelektrisches Bauelement und Verfahren zu dessen Herstellung
DE60311388D1 (de) Drehmomentmessfühler und Verfahren zu dessen Herstellung
DE60323689D1 (de) Schräg geschichtetes furniermaterial und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition